Yi L. Hwa

6.3k citations
64 papers · 1.4k indexed · h-index 22
Topics
Multiple Myeloma Research and Treatments (34 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers)Protein Degradation and Inhibitors (13 papers)
Partner nations
United StatesChinaItaly

In The Last Decade

Yi L. Hwa

61 papers receiving 1.4k citations

Peers

Yi L. Hwa
Comparison fields: 5 of 97
  • Molecular Biology 922
  • Hematology 612
  • Oncology 426
  • Genetics 190
  • Neurology 98
Replace Hatem H. Salem with:
Hatem H. Salem Australia
Weijun Fu China
Achim Obergfell Switzerland
Francesca Cottini United States
Loredana Santo United States
Giuseppina Ruggeri Italy
Anthony E. Dear Australia
Yayoi Shikama Japan
Johanne Poisson France
Carella Am Italy
Yi L. Hwa relative to Hatem H. Salem Australia Hatem H. Salem's profile →
Citations per field
00.5×3.8×
Hatem H. Salem · 1×
Citations per year

Countries citing papers authored by Yi L. Hwa

Since Specialization
Citations

This map shows the geographic impact of Yi L. Hwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi L. Hwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi L. Hwa more than expected).

Fields of papers citing papers by Yi L. Hwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi L. Hwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi L. Hwa. The network helps show where Yi L. Hwa may publish in the future.

Co-authorship network of co-authors of Yi L. Hwa

This figure shows the co-authorship network connecting the top 25 collaborators of Yi L. Hwa. A scholar is included among the top collaborators of Yi L. Hwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi L. Hwa. Yi L. Hwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 6
3 2
4 0
5 2
6 4
7 4
8 10
9 8
10 6
11 56
12 20
13 23
14 41
15 24
16 4
17
Therapeutic Strategies For Initial Treatment Of AL Amyloidosis: Implications Of Therapy and Response On Outcome
2
18 79
19 24
20 2

About Yi L. Hwa

Yi L. Hwa is a scholar working on Hematology, Oncology and Genetics, having authored 64 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (34 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers) and Protein Degradation and Inhibitors (13 papers). The work is most often cited by research in Hematology (612 citations), Genetics (190 citations) and Oncology (426 citations). Yi L. Hwa has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Jin‐Ping Li, Francis K. Buadi, S. Vincent Rajkumar, Shaji Kumar, Prashant Kapoor, Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Sean C. Dowdy and Suzanne R. Hayman. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026